Verma: There Need To Be ‘Serious Discussions’ On How To Pay Sky-High Costs Of Innovative Drugs

CMS Administrator Seema Verma says that the extremely expensive treatments are unlike anything the agency's dealt with in the past, and there needs to be a way to handle such high costs. But she vehemently shot down the idea that Medicare should have negotiating power over drug prices. In other pharmaceutical news: insulin prices, FDA approvals, microbiome drugs, and more.

from Kaiser Health News http://bit.ly/2JViAba